Special Access for the Use of Voclosporin for Kidney Transplantation
Recruitment status was Available
Voclosporin is an investigational medication being studied to prevent acute rejection in patients who receive a kidney transplant. This study is a compassionate release program where subjects previously participating in the study entitled A Phase 2B, Randomized, Multicenter, Open-Label, Concentration Controlled, Safety Study of ISA247 and Tacrolimus (Prograf®) in denovo Renal Transplant Patients (ISA05-01)" may be eligible to continue to receive voclosporin despite the Phase 2B study being terminated by the sponsor. Under the compassionate release program, subjects previously taking voclosporin may continue to receive the study medication until the drug is FDA-approved and commercially available in the United States.
|Study Type:||Expanded Access What is Expanded Access?|
|Official Title:||Special Access for the Use of Voclosporin for Kidney Transplantation|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01236287
|Contact: Meredith J Aull, Pharm.D.||(212) firstname.lastname@example.org|